HONG KONG, Nov 25, 2022 – (ACN Newswire via SEAPRWire.com) – Tianda Pharmaceuticals Limited (“Tianda Pharma” or “the Group”; stock code: 0455.HK) today announced its interim results for the six months ended 30 September 2022 (“the Period”). During the Period, the Group adopted proactive marketing strategy and improved its results notably. Its revenue increased by... » read more
HONG KONG, Jun 30, 2022 – (ACN Newswire via SEAPRWire.com) – Tianda Pharmaceuticals Limited (Tianda Pharmaceuticals or the Group, stock code: 0455.HK) is pleased to announce its annual results for the year ended 31 March 2022. During the Reporting Period, the Group’s business attained further development as revenue reached HK$510.0 million for the Current Financial... » read more
SINGAPORE – One of Singapore’s trailblazing clinician scientists, Professor Wong Tien Yin, who is medical director of the Singapore National Eye Centre (SNEC), is forging a new path in Beijing, China, early next year. Taking the road less travelled, as he is wont to do, he will become the founding head of Tsinghua Medicine, a... » read more
HONG KONG, Nov 26, 2021 – (ACN Newswire via SEAPRWire.com) – Tianda Pharmaceuticals Limited (Tianda Pharma or the Group, stock code: 0455.HK) is pleased to announce its interim results for the six months ended 30 September 2021 (the “Reporting Period”). During the Reporting Period, all three business segments of the Group recorded significant business growth,... » read more
HONG KONG, Oct 7, 2021 – (ACN Newswire via SEAPRWire.com) – ACT Genomics Holdings Co. Ltd. (“ACT Genomics” or “the Group”) announced today that CerbACT Asia (Taipei, Taiwan), a Cerba Research and ACT Genomics joint venture, had unveiled its new purpose-built facility to empower precision medicine for better patient outcomes. The opening ceremony of CerbACT... » read more
HONG KONG, Mar 16, 2021 – (ACN Newswire via SEAPRWire.com) – TDMall (Group) Limited, a subsidiary of Tianda Pharmaceuticals Limited (listed on the main board of the Hong Kong Stock Exchange: 00455) has invested in the establishment of modern-style Chinese medicine clinic – TDMall, and grandly opened its third TDMall in the world, TDMall (Sydney),... » read more
TOKYO, Mar 8, 2021 – (JCN Newswire via SEAPRWire.com) – NEC Corporation (TSE: 6701) today announced that it has joined a landmark public-private initiative, the Norwegian Precision Cancer Medicine Implementation Consortium (CONNECT), a collaboration between 22 key public and private partners for promoting precision cancer medicine. CONNECT is one of four interconnected initiatives in Norway... » read more
HONG KONG, Mar 4, 2021 – (ACN Newswire via SEAPRWire.com) – Tianda Pharmaceuticals Limited (“Tianda Pharmaceuticals”, together with its subsidiaries as the “Group”, Stock Code: 455.HK) is pleased to announce that its wholly-owned subsidiary, Tianda Pharmaceutical (Zhuhai) Co., Ltd., has entered into a Technology Transfer Contract with Heilongjiang Jiren Pharmaceutical Co., Ltd. to acquire the... » read more
SHANGHAI, CHINA, Oct 14, 2020 – (ACN Newswire) – Hua Medicine (the “Company”, Stock Code: 2552.HK) announces that, after review and on-site verification under the Marketing Authorization Holder (“MAH”) system, the Company has obtained the drug manufacturing permit for dorzagliatin, its investigational first-in-class drug, issued by the Shanghai Municipal Drug Administrative Bureau. Since the beginning... » read more